Share the post "Ipca Laboratories announced Financial Results Q1 2024-25"
Highlights
- The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 31.81 % in the past year, substantial increase in net sales/revenue by 2.93 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -54.05 %, Marginal increase in other income during this quarter, up by 117.5%.
- Profit over the Year and quarter: Significant improvement in profitability for Ipca Laboratories Ltd.. Notable increase of 21.35 % in net profit Year to Year, Ipca Laboratories Ltd.’s profitability increased by 14872.93 % in this quarter.
- EPS over the Year and quarter: EPS increased by 18.07 % Year to Year. EPS increased by 222.55 % in previous quarter. Positive impact on shareholders.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 1587.58 Cr | Rs. 2033.01 Cr | Rs. 2092.63 Cr | + 2.93 % | + 31.81 % |
Expenses | Rs. 1282.07 Cr | Rs. 1712.69 Cr | Rs. 1699.91 Cr | -0.75 % | + 32.59 % |
Operating Profit | Rs. 305.51 Cr | Rs. 320.32 Cr | Rs. 392.72 Cr | + 22.6 % | + 28.55 % |
OPM % | 19.24 % | 15.76 % | 18.77 % | + 3.01 % | -0.47 % |
Other Income | Rs. 44.85 Cr | Rs. -117.8 Cr | Rs. 20.61 Cr | + 117.5 % | -54.05 % |
Interest | Rs. 31.38 Cr | Rs. 29.37 Cr | Rs. 24.05 Cr | -18.11 % | -23.36 % |
Depreciation | Rs. 69.27 Cr | Rs. 98.13 Cr | Rs. 98.89 Cr | + 0.77 % | + 42.76 % |
Profit before tax | Rs. 249.71 Cr | Rs. 75.02 Cr | Rs. 290.39 Cr | + 287.08 % | + 16.29 % |
Tax % | 34 % | 96.2 % | 31.48 % | -64.72 % | -2.52 % |
Net Profit | Rs. 164.1 Cr | Rs. 1.33 Cr | Rs. 199.14 Cr | + 14872.93 % | + 21.35 % |
EPS in Rs | Rs. 6.42 | Rs. 2.35 | Rs. 7.58 | + 222.55 % | + 18.07 % |
Today, we’re looking at Ipca Laboratories Ltd.’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 31.81 %. However, it did see a marginal increase of 2.93 % from the previous quarter. Expenses decreased slightly by -0.75 % quarter-on-quarter, aligning with the annual rise of 32.59 %. Operating profit, while up 28.55 % compared to last year, faced a quarter-on-quarter increase of 22.6 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -0.47 %, but an expansion of 3.01 % sequentially. Other income rose by 117.5 % compared to the last quarter, despite an annual decline of -54.05 %. Interest expenses dropped significantly by -18.11 % from the previous quarter, yet the year-over-year decrease remains at a moderate -23.36 %. Depreciation costs climbed by 0.77 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 42.76 %. Profit before tax grew annually by 16.29 % but saw an increase from the preceding quarter by 287.08 %.
Tax expenses as a percentage of profits decreased slightly by -2.52 % compared to last year, with a more notable quarter-on-quarter decrease of -64.72 %. Net profit rose by 21.35 % year-on-year but experienced a 14872.93 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 18.07 % but a quarterly rise of 222.55 %. In summary, Ipca Laboratories Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 1587.58 Cr | Rs. 2033.01 Cr | Rs. 2092.63 Cr | + 2.93 % | + 31.81 % |
Expenses | Rs. 1282.07 Cr | Rs. 1712.69 Cr | Rs. 1699.91 Cr | -0.75 % | + 32.59 % |
Operating Profit | Rs. 305.51 Cr | Rs. 320.32 Cr | Rs. 392.72 Cr | + 22.6 % | + 28.55 % |
Net Profit | Rs. 164.1 Cr | Rs. 1.33 Cr | Rs. 199.14 Cr | + 14872.93 % | + 21.35 % |
EPS in Rs | Rs. 6.42 | Rs. 2.35 | Rs. 7.58 | + 222.55 % | + 18.07 % |
In reviewing Ipca Laboratories Ltd.’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 31.81 % year-on-year growth, however, there was a minor increase of 2.93 % from the previous quarter. Expenses rose by 32.59 % compared to the previous year, with a decrease of -0.75 % quarter-on-quarter. Operating Profit surged by 28.55 % annually, and saw a 22.6 % increase from the last quarter.
Net Profit showed yearly increase of 21.35 %, and experienced a 14872.93 % increase from the previous quarter. Earnings Per Share (EPS) rose by 18.07 % annually, however rose by 222.55 % compared to the last quarter. In essence, while Ipca Laboratories Ltd. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.